Brief: Arix Bioscience Says Amplyx Unveils Expanded Pipeline And Phase 2 Data
17/09/2019 13:09
Sept 17 (Reuters) - Arix Bioscience PLC ARIX.L :
* AMPLYX UNVEILS EXPANDED PIPELINE AND PHASE 2 DATA
* POSITIVE PRELIMINARY DATA FROM ONGOING APX001 PHASE 2
STUDY IN
CANDIDEMIA
* FOLLOWING REVIEW OF SAFETY DATA, DSMB RECOMMENDED THAT
STUDY
CONTINUE ACCORDING TO PROTOCOL
Source text for Eikon: ID:nPRrH5527a
Further company coverage: ARIX.L
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Arix Bioscience
See all newsBrief: Arix Bioscience Says Sale Of Harpoon Is Expected To Deliver Net Proceeds Of About $18.9 Mln
Brief: Arix Bioscience Total NAV Of £228.5 MLN As At 31 October 2023
Brief: RTW Biotech To Acquire Arix Bioscience's Assets
RTW Biotech to acquire Arix Bioscience's assets
Brief: Arix Bioscience Says Board Exploring Range Of Strategic Options For Co